Fix the pricing and insurance coverage and many will come back. Scripts could easily jump to a few thousand. 275 Nx per week, for months. The real question is when will Mannkind get the insurance coverage fixed?
Somebody buying today, almost twice the average volume. Who wouldn't buy down here. Pretty cheap considering housing continues to improve. With this volatility, Darts will be up. Print money, buy back shares, print more money, buy back more shares.
NMB, with the floor on ACSF's loans and dropping rates, do you expect their NAV to increase this report? I expect them to cover the divvy and increase book value, just wondering if I am missing something. Thanks,
Keep in mind, ETFC is going to buy back a lot of stock this yr. Last qtr only 50Million. I am hopeful they buy back 350Million this quarter down in the 22s.
Usually one or two days after the last company they manage. ACSF is on the 8th, I would say they will report the 9th or 10th of Feb.
I am looking forward to their next earnings call. They should use this cash to buy back stock at this discount.
Or after the announcement of sale for $7.50. Smart shorts are covering now. I was hoping for much more when I bought into Mannkind, it is a shame what SNY did to this company.
I read the earnings report, looked pretty good to me. Not sure why down AH. I wish they had bought back shares down here as opposed to $30/sh but in a couple days they can start buying again for this quarter.
Nothing rational about BDC's current prices. Study them hard, stay away from any with Oil exposure and buy the rest. Could double or even triple your money in the next three yrs.
Currently trading at 11 times forward earnings, way under the current market multiple. Going to have to wait until earnings to get a clearer picture. I am hopeful somebody does not know something we do not.
I do not think they will, but they have the ability with board approval. Monday we will see if the market thinks that is good or bad for PSEC shareholders. I think it will be good.
Don't forget how far Afrezza has come. We have 500 people taking it every day with great results. No adverse events in the past year. Yearly sales at current pace of $14MM and growing, albeit slower than anyone would like. With correct pricing and proper insurance coverage, it would not take much to make MNKD profitable. Not to mention at this share price, a company can spend $250 million and take a controlling stake.
bought 3K shares yesterday. CY trades in a pattern. I will buy down here and sell at $10.25. An easy $4,000 gain in, I am betting, 3 weeks.
They need to lower price and get insurance to pick it up in Tier 2. Most of the people who tried Afrezza will probably come back to it if their insurance will cover it. Scripts could easily rise to 2,000 a week with proper insurance coverage, just from the people who have tried it but did not continue because of cost. Getting a contract packager to carton, label and distribute the product is not hard, they can easily move that from SNY within 180 days. Insurance coverage/cost and filing outside of US are the two most important items they need to attack.